A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation‐Positive Non‐Small‐Cell Lung Cancer

A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation‐Positive Non‐Small‐Cell Lung Cancer

ABSTRACT Osimertinib, a standard treatment for epidermal growth factor receptor (EGFR)‐positive non‐small‐cell lung cancer, commonly causes manageable diarrhoea. We report osimertinib‐induced refractory diarrhoea diagnosed as ulcerative colitis, remitting with mesalazine. A 69‐year‐old woman with ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomoki Tamura, Misaki Tani, Hiromichi Ogata, Tomoya Osedo, Masahiro Yamashita, Taisaku Koyanagi, Tatsuya Nishi, Takahiro Umeno, Shoichi Kuyama
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Respirology Case Reports
Subjects:
epidermal growth factor receptor
non‐small cell lung cancer
osimertinib
ulcerative colitis
Online Access:https://doi.org/10.1002/rcr2.70272
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items